UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study

PLoS medicine, 2022-09, Vol.19 (9), p.e1004097-e1004097

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

Nature communications, 2024-05, Vol.15 (1), p.3947-3947, Article 3947

2024

Link zum Volltext

Verfügbarkeit prüfen

Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrations

Virology journal, 2021-04, Vol.18 (1), p.77-77, Article 77

2021

Link zum Volltext

Verfügbarkeit prüfen

Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial

BMC medical research methodology, 2022-02, Vol.22 (1), p.49-49, Article 49

2022

Link zum Volltext

Verfügbarkeit prüfen

Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

PloS one, 2015-05, Vol.10 (5), p.e0126647

2015

Link zum Volltext

Verfügbarkeit prüfen

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

PloS one, 2015-06, Vol.10 (6), p.e0130917-e0130917

2015

Link zum Volltext

Verfügbarkeit prüfen

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

PloS one, 2015-08, Vol.10 (8), p.e0137368-e0137368

2015

Link zum Volltext

Verfügbarkeit prüfen

Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay

Analytica chimica acta, 2019-09, Vol.1071, p.86-97

2019

Link zum Volltext

Verfügbarkeit prüfen

Drug–drug interaction between itraconazole capsule and efavirenz in adults with HIV for talaromycosis treatment

Journal of antimicrobial chemotherapy, 2021-03, Vol.76 (4), p.1041-1045

2021

Link zum Volltext

Verfügbarkeit prüfen

Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)

Clinical infectious diseases, 2021-06, Vol.72 (11), p.2032-2034

2021

Link zum Volltext

Verfügbarkeit prüfen

Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate

Journal of antimicrobial chemotherapy, 2022-03, Vol.77 (4), p.996-999

2022

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

AIDS (London), 2020-02, Vol.34 (2), p.255-260

2020

Link zum Volltext

Verfügbarkeit prüfen

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV

Clinical pharmacokinetics, 2020-10, Vol.59 (10), p.1185-1194

2020

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa

Clinical pharmacology and therapeutics, 2024-05, Vol.115 (5), p.1105-1113

2024

Link zum Volltext

Verfügbarkeit prüfen

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement

Clinical pharmacology and therapeutics, 2021-07, Vol.110 (1), p.36-48

2021

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling

Clinical pharmacokinetics, 2020-11, Vol.59 (11), p.1433-1450

2020

Link zum Volltext

Verfügbarkeit prüfen

Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir

Clinical pharmacokinetics, 2021-06, Vol.60 (6), p.795-809

2021

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate

Antimicrobial agents and chemotherapy, 2021-02, Vol.65 (3)

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s

Antimicrobial agents and chemotherapy, 2023-11, Vol.67 (11), p.e0073723-e0073723

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy

Clinical pharmacokinetics, 2012-10, Vol.51 (10), p.639-659

2012

Link zum Volltext

Verfügbarkeit prüfen

Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

The lancet HIV, 2024-02, Vol.11 (2), p.e86-e95

2024

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older: a PK substudy of the SMILE trial

Journal of antimicrobial chemotherapy, 2023-04, Vol.78 (4), p.1041-1049

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 79

Suche als RSS-Feed

Aktive Filter

ThemaMale

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)

Publikationsform

Artikel
(79)

Sprache

Englisch
(79)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(54)
Humans
(44)
Hiv Infections - Drug Therapy
(33)
Hiv
(31)
Infectious Diseases
(30)
Female
(26)
Pharmacology & Pharmacy
(26)
Pregnancy
(25)
Human Immunodeficiency Virus
(22)
Microbiology
(20)
Adult
(17)
Anti-Hiv Agents - Therapeutic Use
(17)
Immunology
(16)
Pharmacokinetics
(15)
Antiretroviral Drugs
(14)
Infant, Newborn
(14)
Infectious Disease Transmission, Vertical - Prevention & Control
(14)
Anti-Hiv Agents - Pharmacokinetics
(12)
Hiv Infections - Prevention & Control
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study

Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries

Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrations

Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes

Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

Correction: Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV

Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay

Drug–drug interaction between itraconazole capsule and efavirenz in adults with HIV for talaromycosis treatment

Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV)

Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate

Development and validation of the first point-of-care assay to objectively monitor adherence to HIV treatment and prevention in real-time in routine settings

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV

Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa

Efficacy and Safety of 1-Month Postpartum Zidovudine-Didanosine to Prevent HIV-Resistance Mutations after Intrapartum Single-Dose Nevirapine

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement

Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling

Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir

Population Pharmacokinetics of Tenofovir in Pregnant and Postpartum Women Using Tenofovir Disoproxil Fumarate

Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s

Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy

Paediatric abacavir–lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older: a PK substudy of the SMILE trial

Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus

Aktive Filter

Suchergebnisse filtern